Branded supply is the half of this business people assume we do not do. M Care Exports is known as a generics house, and most of the volume is generic, but the same licensed Indian wholesale market that carries ten thousand generic SKUs also carries the originator brands, bought from the originator's own Indian entity or its appointed distributors. We quote both. What follows is how the branded half actually works, written so that a buyer can tell a licensed offer from a grey one in the first five minutes of a conversation.
What branded supply means, and what it never means.
Branded supply means the originator's finished product: the sealed pack the innovator company placed on the Indian market, with its batch number, expiry and storage history intact, exported to a buyer whose own import basis allows it in. Three words matter there. Sealed, because a repacked carton has no provenance. Originator, because a copy of a patented molecule is not a generic, it is an infringement or a compounded preparation. Import basis, because lawfulness is decided at the destination, not at the airport in Mumbai.
Some examples make the categories concrete.
| Brand | Molecule | Originator | What a buyer should know |
|---|---|---|---|
| Mounjaro / Zepbound | tirzepatide | Eli Lilly | Under patent into the mid-2030s. No licensed generic exists anywhere; brand supply is the only lawful supply. |
| Ozempic / Rybelsus / Wegovy | semaglutide | Novo Nordisk | One molecule, a weekly pen and a daily tablet. Brand-only in most markets today. |
| Keytruda | pembrolizumab | MSD | A biologic on a strict 2–8 °C chain. Patent expiries begin in the late 2020s; until biosimilars land, brand is the supply. |
| Herceptin | trastuzumab | Genentech (Roche) | Licensed biosimilars exist (Ogivri and others), so here brand versus biosimilar is genuinely the buyer's choice. |
| Revlimid | lenalidomide | Bristol Myers Squibb | Licensed generics now exist in several markets; the brand remains specified in some tenders and named-patient files. |
What branded supply never means: compounded vials of a patented molecule, stock without an invoice trail, or a “generic” of a product whose patents are still running. Those offers exist, they are usually cheaper, and they are the subject of the red-flags section below.
Why brands are sourced from India at all.
Because the originators themselves sell here. Every company in the table above operates in India through its own subsidiary or appointed licensed distributors, and lists the same product at a price set for the Indian market. The pack is the originator's pack. The price is India's. For a hospital pharmacy, a tender desk or a licensed wholesaler in a market where the same brand lists far higher, that differential is the entire commercial case.
Two more practical reasons keep the lane busy. India's pharmaceutical wholesale market is deep, so branded stock in tender quantities is genuinely available rather than theoretical. And the paper is in English: drug licences, invoices and batch certificates can be read by the buyer's own auditor without translation.
One honest caveat belongs here rather than in the small print. Whether a brand bought in India may enter your market is your market's question. Some regulators admit it through hospital, named-patient or unlicensed-import routes, the way GCC hospitals bring in unlicensed lines; some admit parallel imports; some refuse both. The exporter who tells you India-side paperwork settles the matter is wrong on purpose.
The lawful route, in five steps.
- Destination permission first. The importer of record, you or your consignee, holds the import basis: a wholesale import licence, a hospital or named-patient approval, or a tender award. Nothing ships before this exists, because the permission decides pack language, labelling and quantity.
- Quote against licensed stock. The offer names the brand, strength, pack, batch, expiry and the licensed source category, at a price that reflects the real Indian trade price. A serious quote survives being checked against it.
- Provenance pack assembled. Invoice chain in which every holder of the stock has a drug licence, batch certificate of analysis, and storage records. This is the paper that separates the licensed market from the grey one.
- Cold chain booked, where the product demands it. Pens and biologics travel at 2–8 °C with a logger in the carton and the excursion protocol agreed before packing, the same discipline we run on West African cold-chain lanes.
- Export clearance from India. Pharmaceutical export is itself a licensed activity, cleared through the drug controller's port office and customs, with the export papers naming the same batches the buyer will receive.
M Care Exports runs this route as the exporter of record: an Indian merchant exporter, ISO 9001:2015 certified, sourcing brands through licensed Indian channels and generics from WHO-GMP certified manufacturers, with the destination importer holding the import permission throughout.
Five offers a careful buyer refuses.
- Compounded GLP-1 vials sold as equivalents. A vial of “semaglutide” or “tirzepatide” is neither Ozempic nor Mounjaro nor a generic of either. The US FDA has published its concerns with unapproved GLP-1 products and has tightened the compounding position as brand supply stabilised.
- No invoice chain. Stock that cannot show a licensed trail is stock nobody can verify, whatever the carton looks like.
- A price below the Indian trade price. If the quote undercuts the licensed Indian market, the stock did not come from it. The discount is the warning.
- Repacked or stickered cartons. Batch and expiry on the pack must match the certificate and the invoice. A resealed carton has no provenance to sell.
- “Generic” versions of patented brands. While tirzepatide's patents run, generic Mounjaro is not a product that exists. An offer of one tells you everything about the supplier.
What to send for a branded quote.
Four facts: the brand and strength, the destination market and your import basis, the quantity, and the cold-chain delivery point if the line needs one. Send them through Request a medicine or the trade account desk and the Mumbai team replies within one working day, including when the honest answer is that your market's rules keep the route shut.
Frequently asked
Is it legal to import branded medicines from India?
It depends entirely on the destination market's import rules, not on India's willingness to export. The lawful pattern is that the importer of record holds the import permission, a wholesale licence, a hospital or named-patient approval, or a tender award, and the Indian exporter ships against it through a fully licensed chain. An exporter offering to ship without asking about your import basis is describing the unlawful pattern.
Why are originator brands cheaper in India?
Originator companies price the same product differently in different markets. The pack sold in India by the originator's own entity or licensed distributor is the same molecule from the same company, listed at a price set for the Indian market. That differential, not any difference in the product, is the commercial case.
Is there a generic version of Mounjaro (tirzepatide)?
No licensed generic exists. Tirzepatide remains under patent in every major market into the mid-2030s, so the only lawful supply is the originator brand, Mounjaro or Zepbound from Eli Lilly. Anything offered as generic tirzepatide, or a compounded vial presented as equivalent, is not a licensed product.
Does M Care Exports supply brands as well as generics?
Yes, both. Originator brands sourced through licensed Indian channels, and generics from WHO-GMP certified manufacturers. Brand or generic is the buyer's call per line, quoted against the destination market.
What documents prove a branded consignment is genuine?
The provenance chain: an invoice trail in which every holder of the stock has a drug licence, batch certificates of analysis matching the batch and expiry on the sealed packs, temperature records for cold-chain lines, and export papers naming the same batches. If any hand in the chain cannot be papered, the consignment cannot be verified.
What about compounded semaglutide or tirzepatide?
Neither the brand nor a generic. The US FDA has published its concerns about unapproved GLP-1 products marketed for weight loss. A licensed branded chain trades sealed originator packs with batch traceability, and nothing else.
Send the specifics. We will scope it honestly.
Molecule, strength, volume and destination. The Mumbai desk replies within one working day, including when the answer is that the route is not viable yet.